Check out our COVID-19 dedicated page for tenders related to medical equipment needs.
Italy-Benevento: Research and experimental development services
Prior information notice
This notice is for prior information only
Section I: Contracting authority
According to Article No 158, paragraph No 2 of Italian Legislative Decree No 50/2016 — this PCP is carried out by A.S.L. Benevento as lead procurer to coordinate the joint procurement.
Section II: Object
Pre-commercial Procurement (PCP) to Buy R&D (Research and Development) Services to developing Digital Solutions Supporting Continuum of Care for Frailty Prevention in Old Adults — eCARE
This PIN provides early information about the expected starting date and purchase volume for a pre-commercial procurement (PCP) and about the open market consultation that is organised in preparation of this procurement.
The procurement aimsto deliver disruptive digital solutions for the prevention and comprehensive management of frailty to encourage independent living, wellbeing and to relieve health and care services budget pressure, throughout the implementation of a pre-commercial procurement scheme. Solutions should improve outcomes for frailty in old adults entailing the physical and the psychosocial factors. The target group are the pre-frail/frail old adults with emphasis on those that feel lonely and/or isolated.
The procurers will procure the development, testing and implementation of digital tools/services and communication concepts to facilitate the transition to integrated care models across health and social services and country-specific cross-institutional set-ups.
— one international webinar: data on the website;
— four national webinars:
• Wroclaw (Poland) — 21 October 2020,
• Santander (Spain) — 22 October 2020,
• Barcelona (Spain) — 28 October 2020,
• Benevento (Italy) — 29 October 2020.
The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to a number of R&D providers in parallel in a phased approach. Each selected operator will be awarded a framework agreement that covers three R&D phases (described below). After each phase, intermediate evaluations will be carried out to progressively select the best of the competing solutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the next phase.
• Phase A. Solution design:
This phase is a feasibility study of the selected technologies and proposals, which aims to verify the technical, economic and organisational feasibility of each company’s offer. The expected output from participating companies is a report describing the results of the feasibility study. The expectation is that this phase will last for 6 months. The budget for the R&D contracts in this phase is EUR 321 311 475 (excluding VAT). From this sum a maximum of eight contracts will be awarded.
• Phase B. Prototype development:
The purpose of this phase is to develop the most promising ideas, shown in phase A, into well-defined prototypes. The selection process for phase B is based on the phase A report and an application process, which will outline the company’s plans for phase B.
Selected companies will each develop a prototype based on the results of their feasibility study. The aim is to verify to what extent the prototype’s main features meet the functional and performance requirements set in the challenge. Participating companies are expected to deliver a prototype specification and lab demonstration, as well as a plan for original development of a limited volume of first solutions and field-testing, and an updated cost/benefits evaluation including a preliminary business plan.
It is expected that the combined budget for this phase will be EUR 1 606 577 377 (excluding VAT). A maximum of four projects will be selected for phase B and this phase is expected to take up to 12 months.
• Phase C. Pre-commercial development, field test:
This phase aims to verify and compare the full feature set and performance of different solutions in real-life operational conditions of the targeted public service. Expected output from participating companies includes field testing, field test specification, specification of the final solution, other related technical documentation and an updated cost/benefit evaluation.
This phase will last maximum 14 months with no more than two solutions progressing to this phase. It is expected that the combined budget for this phase will be EUR 1 285 245 804 (excluding VAT). All the solutions in phase C will be tested in all the sites to ensure that a comparison can be made of performance both across sites and across solutions. Each procurer will identify a sample population to implement the proof of concept of the final awarded solutions.
Testing is expected to take place in:
— Province of Benevento,
— Area of Barcelona and BaixLlobregat,
— City of Santander,
— Falkiewicz Hospital.
The procurement is expected to start in 1 March 2021 and end in 29 February 2024.The PCP challenge, requirements, conditions and awarded criteria will be established in the tender documents. They will be available from the end of February at https://ecare-pcp.eu/
The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions. The procurers will enjoy royalty-free access rights to use the R&D results for their own use. The procurers will also enjoy the right to grant or to require participating R&D providers to grant non-exclusive licenses to third parties to exploit the results under fair and reasonable market conditions without any right to sublicense.
The framework agreement will detail the terms of the ownership of the results and its exploitation.
Open market consultation will take place from 1 October 2020 to 31 November 2020 and include:
— one international webinar: to be announced on the website;
• Benevento (Italy) — 29 October 2020,
— two online questionnaires (supply-side/demand-side) available on the website on 1 October 2020.
Section IV: Procedure
Section VI: Complementary information
This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. This is because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs.
Publication of this contract notice in the EU Official Journal is not to be understood as a waiver of this exemption. Publication is made on a voluntary basis and the procurement will not follow the procedures under the EU public procurement directives, but rather the procedure described in the tender documentation.
This PIN is published to announce an open market consultation on a future procurement procedure. The PIN is not a commitment to procure.